知镜 Cognispect · 医学文献与研究工作台

Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Bacha Z, Shahbaz H, Yasir A, Afridi H, Rashad A, Muneer H, Gohar F, Khan M, Chaudhary MA, Rehman A, Abid M, Afridi MS, Naqvi M, Khan FM, Rahat S, Rafi F, Hassanabad AF.
Cardiology in review · 2026-10-29 · PMID 42951893

文献摘要

Concomitant coronary artery disease affects 40-75% of patients undergoing transcatheter aortic valve implantation (TAVI). Three recent randomized trials yielded conflicting findings: NOTION-3 demonstrated reduced composite events with pre-TAVI percutaneous coronary intervention (PCI), whereas PRO-TAVI showed non-inferiority of PCI deferral with less bleeding; neither demonstrated mortality benefit. No previous meta-analysis combined all 3 trials with observational evidence, applied design-stratified GRADE certainty, or explored cardiovascular mortality heterogeneity. We performed a systematic review and meta-analysis of 16 studies (3 randomized trials, 13 observational cohorts; 8,207 patients). Ten prespecified outcomes were pooled using Mantel-Haenszel random-effects risk ratios (RRs) with 95% confidence intervals (CIs); 30-day all-cause mortality was primary. GRADE certainty was assessed separately for randomized and observational evidence. Prespecified design-based subgroup and leave-one-out sensitivity analyses were performed. Pre-TAVI PCI was not associated with significant differences in 30-day all-cause mortality (RR 1.26, 95% CI 0.90-1.77; I2 = 32%) or 1-year mortality (RR 1.00, 95% CI 0.87-1.15; I2 = 0%). Major bleeding (RR 1.19, 95% CI 0.98-1.44) and major vascular complications (RR 1.48, 95% CI 0.95-2.30) showed borderline non-significant trends favoring PCI deferral (both I2 = 0%). Excluding Griese et al. 2014, the principal driver of harm and heterogeneity, reduced cardiovascular mortality heterogeneity (RR 0.91; I2 = 24%). No significant differences occurred in stroke, myocardial infarction, acute kidney injury, pacemaker implantation, or rehospitalization. Routine pre-TAVI PCI confers no mortality benefit and may increase bleeding and vascular complications; PCI should be individualized according to coronary complexity, lesion significance, and bleeding risk.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。